Cediranib (AZD2171) for cell activation
Catalog number
1613-5
Name
Cediranib (AZD2171) for cell activation
Size
5 mg
Price
480.00 EUR
Supplier
Details
Description
Cediranib (AZD2171) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less.
Peptide sequence
N/A
CAS number
288383-20-0
Molecular weight
450.51
Category
Biochemicals
Other name
AZD2171, Recentin
Molecular formula
C₂₅H₂₇FN₄O₃
Physical appearance
Crystalline solid
Supplied with
N/A
Is this a salt?
No
Is it cell-permeable?
Yes
Purification
≥98%
Reconstitute instructions
DMSO (10 mM)
Storage condition
-20°C
Shipping condition
RT
Maximum time for storage
24months
Storage instructions
Protect from air and moisture
Tissue
cell
Additional description
For cells, cell lines and tissues in culture till half confluency.
